Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.74%81.14B | 0.98%322.65B | 11.56%80.83B | 9.30%86.39B | -4.01%82.82B | -11.17%72.61B | -8.62%319.5B | -16.84%72.46B | -12.03%79.03B | -2.88%86.27B |
Cost of revenue | 6.35%63.66B | 10.82%257.19B | 1.47%64.62B | 15.38%67.09B | 18.16%65.63B | 9.39%59.85B | 3.31%232.09B | 11.55%63.68B | 3.17%58.15B | -0.10%55.54B |
Gross profit | 37.02%17.48B | -25.12%65.46B | 84.75%16.22B | -7.61%19.3B | -44.08%17.18B | -52.78%12.76B | -30.05%87.42B | -70.78%8.78B | -37.61%20.89B | -7.54%30.73B |
Operating expense | 11.35%14.85B | 1.69%56.38B | 10.13%14.18B | -0.21%14.4B | 1.45%14.46B | -3.91%13.34B | -2.33%55.44B | -8.80%12.88B | -8.90%14.43B | 3.84%14.26B |
Operating profit | 555.19%2.63B | -71.61%9.08B | 149.67%2.04B | -24.14%4.9B | -83.49%2.72B | -104.40%-578M | -53.12%31.98B | -125.75%-4.1B | -63.38%6.46B | -15.55%16.48B |
Net non-operating interest income (expenses) | 75.48%272M | 96.15%510M | 68.10%195M | -64.86%39M | 89.06%121M | 600.00%155M | 326.09%260M | 268.12%116M | 428.57%111M | 3,300.00%64M |
Non-operating interest income | 51.89%442M | 83.13%1.32B | 54.51%377M | 52.86%347M | 71.67%309M | 304.17%291M | 162.91%723M | 662.50%244M | 100.88%227M | 76.47%180M |
Non-operating interest expense | 25.00%170M | 50.76%698M | 42.19%182M | 65.52%192M | 62.07%188M | 32.04%136M | 18.72%463M | 26.73%128M | 26.09%116M | 11.54%116M |
Total other finance cost | ---- | --116M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net investment income | 187.33%5.37B | 235.67%4.02B | 13,186.67%3.93B | 8.06%-3.97B | 38.80%2.19B | -52.85%1.87B | -63.93%1.2B | -101.46%-30M | -782.31%-4.32B | 132.01%1.58B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -92.68%12M | 177M | 13M | 0 | 0 | 164M | 0 | 0 | 0 | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -194.51%-268M | 73.58%-999M | 80.31%-630M | -1,528.57%-100M | 53.65%-178M | 55.61%-91M | -322.46%-3.78B | -551.53%-3.2B | 111.29%7M | -14.97%-384M |
Less:Other special charges | 183.33%204M | -76.79%861M | -81.76%576M | 414.29%66M | -60.59%147M | -63.82%72M | 484.09%3.71B | 807.47%3.16B | -145.65%-21M | 43.46%373M |
Less:Write off | 236.84%64M | 91.67%138M | 31.71%54M | 142.86%34M | 181.82%31M | 216.67%19M | -72.31%72M | -71.33%41M | -12.50%14M | -85.14%11M |
Other non-operating income (expenses) | 161.71%166M | -80.15%287M | -73.51%196M | -28.40%237M | -49.38%123M | -303.79%-269M | 70.32%1.45B | 102.19%740M | 209.35%331M | 19.12%243M |
Income before tax | 554.28%8.19B | -57.97%13.07B | 188.65%5.74B | -57.48%1.1B | -72.30%4.98B | -92.64%1.25B | -56.73%31.1B | -136.41%-6.47B | -85.86%2.59B | -11.90%17.98B |
Income tax | 439.08%1.88B | -39.70%4.76B | 138.70%1.1B | 33.01%826M | -53.46%2.48B | -92.70%348M | -54.96%7.89B | -153.73%-2.84B | -87.42%621M | 8.30%5.34B |
Net income | 598.67%6.31B | -64.18%8.32B | 227.61%4.64B | -86.01%276M | -80.25%2.5B | -92.62%903M | -57.29%23.22B | -129.09%-3.64B | -85.29%1.97B | -18.32%12.64B |
Net income continuous operations | 598.67%6.31B | -64.17%8.32B | 227.61%4.64B | -85.96%277M | -80.25%2.5B | -92.62%903M | -57.29%23.22B | -129.09%-3.64B | -85.29%1.97B | -18.33%12.64B |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 598.67%6.31B | -64.18%8.32B | 227.61%4.64B | -86.01%276M | -80.25%2.5B | -92.62%903M | -57.29%23.22B | -129.09%-3.64B | -85.29%1.97B | -18.32%12.64B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 598.67%6.31B | -64.18%8.32B | 227.61%4.64B | -86.01%276M | -80.25%2.5B | -92.62%903M | -57.29%23.22B | -129.09%-3.64B | -85.29%1.97B | -18.32%12.64B |
Gross dividend payment | ||||||||||
Basic earnings per share | 598.21%50.62 | -64.17%66.75 | 227.66%37.25 | -86.04%2.21 | -80.25%20.04 | -92.62%7.25 | -57.02%186.32 | -129.16%-29.18 | -85.18%15.83 | -17.68%101.47 |
Diluted earnings per share | 536.98%45.99 | -65.81%63.49 | 219.81%34.96 | -91.57%1.33 | -80.24%19.98 | -92.63%7.22 | -57.03%185.71 | -129.24%-29.18 | -85.19%15.77 | -17.73%101.12 |
Dividend per share | 0 | 0.00%90 | 0.00%45 | 0 | 0.00%45 | 0 | 12.50%90 | 12.50%45 | 0 | 12.50%45 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |